Phase 2 Postherpetic Neuralgia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Y-4 to Treat the Postherpetic Neuralgia
Postherpetic NeuralgiaPregabalinY-4
Neurodawn Pharmaceutical Co., Ltd.160 enrolled1 locationNCT07275762
Not Yet Recruiting
Phase 2Phase 3
A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients with Postherpetic Neuralgia.
Postherpetic Neuralgia
Andros Pharmaceuticals Pty Ltd333 enrolled1 locationACTRN12625001044415
Completed
Phase 2
A Phase II, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of topical lidocaine spray in patients with Postherpetic Neuralgia
Postherpetic Neuralgia
Andros Pharmaceuticals Pty Ltd30 enrolled1 locationACTRN12618000852257
Completed
Phase 2
A study of oral EMA401 in the treatment of pain following shingles to see if EMA401 can reduce the level of pain.
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd172 enrolled6 locationsACTRN12611000822987